Skip to content

Clinical trials

Autism Spectrum Disorder trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Country / region: Australia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20172
20182
20191
20215
20224
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Not yet recruiting2
Recruiting2
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fenix Innovation Group3
Curtin University2
MapLight Therapeutics2
The University of Queensland2
University Medical Centre Ljubljana2
Bristol-Myers Squibb1
Forest Laboratories1
Great Ormond Street Hospital for Children NHS Foundation Trust1
Institut de Recherches Internationales Servier1
Jazz Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder20
Autistic Disorder5
Anxiety Disorders3
Learning Disabilities2
Neurodevelopmental Disorders2
Asperger Syndrome1
Asthma1
Death1
Gastrointestinal Diseases1
Marijuana Abuse1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.